Biopharmaceutics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
Aims and scope
The Section ‘’Biopharmaceutics” of the open-access journal Pharmaceutics will publish novel, original, peer-reviewed research manuscripts, short communications, and invited topical reviews in all areas of Biopharmaceutics. “Biopharmaceutics” focuses on fundamental and applied research, including the relationship between a drug’s pharmacokinetic, physical, and chemical properties, the dosage form or delivery system into which it is included, the route of administration, and the resulting therapeutic and toxic response. In particular (but not exclusively), this Section invites contributions that report on these topics:
Concepts in ADME and drug exposure
- Absorption: mechanisms and routes of absorption, absorption enhancement;
- Drug distribution: mechanisms, kinetics and approaches to drug targeting;
- Drug elimination: metabolism and excretion, processes and kinetics, metabolites and prodrugs;
- Impact of physiological and pathological factors on drug absorption, distribution, metabolism and excretion (ADME);
- Variability in ADME and special populations;
- Bioavailability and bioequivalence;
- Pharmacokinetics and the PK–PD relationship;
- ADME of biologicals.
Dosage forms
- Drug release: mechanisms and factors that impact the process;
- Strategies and formulations for controlled drug transport across biological barriers;
- Targeted drug delivery at organic, tissue, molecular, cellular levels;
- Novel drug delivery technologies;
- Personalized dosage forms;
- Pharmaceutical preformulation and formulation developments;
- Optimizing the safety and efficacy of therapies through medicines design;
- Modulating ADME through medicine design.
Integration of drug dosage and form biology concepts
- In vitro/in vivo correlations;
- Preclinical and clinical evaluation of formulation technologies and drug delivery systems;
- Biological membranes: modelling and simulation, drug transport;
- Understanding of biological barriers to drug release in health and disease.
Authors will enjoy a high-quality review process, rapid publication, and high visibility through access to a broad readership.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- In Vitro and In Vivo Studies of Natural Antimicrobial Peptides as Promising Therapeutic Agents (Deadline: 30 June 2024)
- Pharmaceutical Formulations and Bioavailability Enhancement Techniques for Transmucosal Drug Delivery (Deadline: 30 June 2024)
- Functional Peptide-Based Biomaterials for Biomedical Applications (Deadline: 30 June 2024)
- Plant Extracts and Their Biomedical Applications (Deadline: 30 June 2024)
- Advances in ADME for Drug Discovery (Deadline: 10 July 2024)
- Anti-inflammatory Effects from Natural Bioactive Compounds—from Bench to Bedside, 2nd Edition (Deadline: 20 July 2024)
- Natural and Synthetic Compounds in Pharmaceutical Formulations and Drug Delivery Systems (Deadline: 31 July 2024)
- Recent Advances in Natural Product Drugs, 2nd Edition (Deadline: 31 July 2024)
- Phenolic Acids: Handy Molecules for Medicinal Purposes (Deadline: 31 July 2024)
- Bioactive Molecules from Plants: Discovery and Pharmaceutical Applications, 3rd Edition (Deadline: 10 August 2024)
- Drug–Drug Interactions—New Approaches and Perspectives (Deadline: 10 August 2024)
- New Approach to Anti-inflammation, Antibacterial and Anti-cancer Therapy: Natural Extracts (Deadline: 10 August 2024)
- Recent Advances in Pharmaceutical Applications of Functionalized Polysaccharides and Their Derivatives, 2nd Edition (Deadline: 20 September 2024)
- Skin Care Products for Healthy and Diseased Skin (Deadline: 30 September 2024)
- The Role of Free Radicals and Antioxidants in Drug Activation and Effectiveness in Different Biological Systems (Deadline: 20 October 2024)
- Drug Product Performance: Bioavailability, Relative Bioavailability and Bioequivalence, 2nd Edition (Deadline: 20 October 2024)
- Bionanomaterials: Fascinating Materials for Biomedical Applications (Deadline: 30 October 2024)
- Natural Products for Anticancer Application (Deadline: 31 October 2024)
- New Insights into Transporters in Drug Development (Deadline: 10 November 2024)
- Natural Pharmaceuticals Focused on Anti-inflammatory Activities (Deadline: 30 November 2024)
- Antimicrobial Peptides and Their Potential Pharmaceutical Applications (Deadline: 10 January 2025)